首页 > 最新文献

VNU Journal of Science: Medical and Pharmaceutical Sciences最新文献

英文 中文
Investigation of Lyophilized Microspheres Loaded with Leuprolide Acetate 载醋酸Leuprolide的冻干微球的研究
Pub Date : 2023-03-25 DOI: 10.25073/2588-1132/vnumps.4487
Nguyen Thanh Lam, Ngo Giao Thong, Tran Thi My Duyem, Bui Thi Thuong, Tran Thi Hai Yen
Abstract: Leuprolide acetate (LA) - a nonapeptide, used for the treatment of some hormone-depending diseases, is unstable and very susceptible to degradation in the aqueous media. Poly (lactic-co-glycolic) acid (PLGA) is a copolymer of lactide and glycolide, that has generated tremendous interest in pharmaceutics because of their excellent biocompatibility, biodegradability, and mechanical strength. PLGA is used for the preparation of biocompatible biodegradable extended-release microspheres. However, the PLGA undergoes hydrolytic degradation in an aqueous environment through cleavage of its backbone ester linkages. As a consequence, PLGA-based microspheres loaded with LA are usually lyophilized to ensure the stability of LA and PGLA and reduce agglomeration, sedimentation, and size change of microspheres during storage. The aim of this present study is to evaluate the influence of lyoprotectants namely mannitol, trehalose, lactose, and saccharose on the stability of LA and characteristics of PLGA-based microspheres loaded with LA upon lyophilization. DSC and FTIR were used to evaluate the biocompatibility of LA and lyoprotectants. The results showed that there was no incompatibility between the LA and lyoprotectants. Mannitol solution 1.25% was used in freeze-drying PLGA-based microspheres loaded with LA. The obtained lyophilized microspheres had a good appearance and low moisture. Lyophilized microspheres after reconstitution had no significant change in drug content, size, and size distribution in comparison to that before freeze-drying. Keywords: Leuprolide acetate, PGLA, lyophilized, stability, biodegradable microspheres.    
摘要:醋酸Leuprolide acetate (LA)是一种用于治疗某些激素依赖性疾病的非肽类物质,在水介质中不稳定且极易降解。聚乳酸-共乙醇酸(PLGA)是丙交酯和乙醇酸的共聚物,由于其优异的生物相容性、生物可降解性和机械强度,在制药领域引起了极大的兴趣。PLGA用于制备生物相容性可生物降解的缓释微球。然而,PLGA在水环境中通过其主链酯键的裂解进行水解降解。因此,为了保证LA和PGLA的稳定性,减少微球在储存过程中的团聚、沉淀和尺寸变化,通常会对负载LA的plga微球进行冻干处理。本研究的目的是评估冻干保护剂(甘露醇、海藻糖、乳糖和蔗糖)对LA稳定性的影响以及负载LA的plga微球在冻干后的特性。用DSC和FTIR评价了LA和lyo保护剂的生物相容性。结果表明,LA与lyo保护剂之间不存在不相容性。用1.25%的甘露醇溶液冷冻干燥负载LA的plga基微球。所得的冻干微球具有良好的外观和低水分。与冷冻干燥前相比,重组后的冻干微球在药物含量、大小和大小分布方面没有明显变化。关键词:醋酸Leuprolide PGLA冻干稳定性可生物降解微球
{"title":"Investigation of Lyophilized Microspheres Loaded with Leuprolide Acetate","authors":"Nguyen Thanh Lam, Ngo Giao Thong, Tran Thi My Duyem, Bui Thi Thuong, Tran Thi Hai Yen","doi":"10.25073/2588-1132/vnumps.4487","DOIUrl":"https://doi.org/10.25073/2588-1132/vnumps.4487","url":null,"abstract":"Abstract: Leuprolide acetate (LA) - a nonapeptide, used for the treatment of some hormone-depending diseases, is unstable and very susceptible to degradation in the aqueous media. Poly (lactic-co-glycolic) acid (PLGA) is a copolymer of lactide and glycolide, that has generated tremendous interest in pharmaceutics because of their excellent biocompatibility, biodegradability, and mechanical strength. PLGA is used for the preparation of biocompatible biodegradable extended-release microspheres. However, the PLGA undergoes hydrolytic degradation in an aqueous environment through cleavage of its backbone ester linkages. As a consequence, PLGA-based microspheres loaded with LA are usually lyophilized to ensure the stability of LA and PGLA and reduce agglomeration, sedimentation, and size change of microspheres during storage. The aim of this present study is to evaluate the influence of lyoprotectants namely mannitol, trehalose, lactose, and saccharose on the stability of LA and characteristics of PLGA-based microspheres loaded with LA upon lyophilization. DSC and FTIR were used to evaluate the biocompatibility of LA and lyoprotectants. The results showed that there was no incompatibility between the LA and lyoprotectants. Mannitol solution 1.25% was used in freeze-drying PLGA-based microspheres loaded with LA. The obtained lyophilized microspheres had a good appearance and low moisture. Lyophilized microspheres after reconstitution had no significant change in drug content, size, and size distribution in comparison to that before freeze-drying. \u0000Keywords: Leuprolide acetate, PGLA, lyophilized, stability, biodegradable microspheres. \u0000  \u0000 ","PeriodicalId":23520,"journal":{"name":"VNU Journal of Science: Medical and Pharmaceutical Sciences","volume":"60 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83006189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Vivo Bioequivalence Study of Drug: An Analysis of Related Regulations in Current Pharmaceutical Legislation in Vietnam 药物体内生物等效性研究:越南现行药品立法相关法规分析
Pub Date : 2023-03-25 DOI: 10.25073/2588-1132/vnumps.4474
Tang Quoc Hung, Nguyen Thi Thanh Hai, Tran Bich Ngoc
Abstract: Implementation of in vivo bioequivalence study is a growing trend in the pharmaceutical industry in Vietnam and over the world. These studies are required in order to demonstrate whether a generic drug is a bioequivalence to an innovator’s drug or to an original brand name drug. At present, there are 26 active ingredients that have to provide in vivo bioequivalence study report for drug registration in Vietnam. In the next few years, this number will gradually increase. Therefore, the government should introduce promotion, development, and preferential policies for enterprises to invest in these ingredients. This paper aims to provide general guidelines on regulations of in vivo bioequivalence studies for pharmaceutical enterprises in Vietnam and support the initial implementation of these studies in practice. Keywords: Bioequivalence, BABE, BE, Regulations.
摘要:实施体内生物等效性研究是越南乃至世界制药行业的发展趋势。这些研究是为了证明仿制药是否与创新药物或原始品牌药物具有生物等效性。目前,有26种活性成分必须提供体内生物等效性研究报告才能在越南进行药品注册。在接下来的几年里,这个数字将逐渐增加。因此,政府应该出台促进、发展和优惠政策,鼓励企业投资这些成分。本文旨在为越南制药企业提供体内生物等效性研究法规的一般指南,并支持这些研究在实践中的初步实施。关键词:生物等效性,BABE, BE,法规
{"title":"In Vivo Bioequivalence Study of Drug: An Analysis of Related Regulations in Current Pharmaceutical Legislation in Vietnam","authors":"Tang Quoc Hung, Nguyen Thi Thanh Hai, Tran Bich Ngoc","doi":"10.25073/2588-1132/vnumps.4474","DOIUrl":"https://doi.org/10.25073/2588-1132/vnumps.4474","url":null,"abstract":"Abstract: Implementation of in vivo bioequivalence study is a growing trend in the pharmaceutical industry in Vietnam and over the world. These studies are required in order to demonstrate whether a generic drug is a bioequivalence to an innovator’s drug or to an original brand name drug. At present, there are 26 active ingredients that have to provide in vivo bioequivalence study report for drug registration in Vietnam. In the next few years, this number will gradually increase. Therefore, the government should introduce promotion, development, and preferential policies for enterprises to invest in these ingredients. This paper aims to provide general guidelines on regulations of in vivo bioequivalence studies for pharmaceutical enterprises in Vietnam and support the initial implementation of these studies in practice. \u0000Keywords: Bioequivalence, BABE, BE, Regulations.","PeriodicalId":23520,"journal":{"name":"VNU Journal of Science: Medical and Pharmaceutical Sciences","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74795244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Features of the Circle of Willis on Multislice Computed Tomography in Humans Without Cerebral Vascular Malformations 无脑血管畸形人多层计算机断层扫描Willis环的特征
Pub Date : 2023-03-25 DOI: 10.25073/2588-1132/vnumps.4351
Doan Van Ngoc, Tran Anh Tuan, Hoang Dinh Au
Abstract: A study of 135 cases without cerebral vascular malformations who were scan MSCT of cerebral arteries at Bach Mai hospital during the period from January 2019 to December 2019. Result: mean diameter of cerebral artery segments: left and right A1 segments: 2.28 ± 0.47 and 2.19 ± 0.53 mm; AcomA: 1.71 ± 0.68 mm; left and right M1 segments: 2.82 ± 0.46 mm and 2.8 ± 0.49 mm; left and right PcomA: 1.62 ± 0.5 mm and 1.67 ± 0.48 mm; left and right P1 segments: 2.22 ± 0.49 mm and 2.22 ± 0.56 mm; left and right P2 segments: 2.32 ± 0.38 mm and 2.35 ± 0.36 mm; BA: 3.41 ± 0.69 mm. The diameters of the cerebral arteries were similar in both sexes, with no difference on the right and left sides of the ring of Willis. The diameter of the edges of the Willis circle varied from aplastic and hypoplastic, which was mainly seen in the AcomA, PcomA, the A1 segment of the anterior cerebral artery, and P1 of the posterior cerebral artery. The transformations of the Willis ring included 17 forms, of which four simple transformations of the anterior part, four simple transformations of the posterior part, and nine combined transformations between the anterior and posterior parts. Mainly found aplasia or hypoplasia of the AcomA 14.1% and the PcomA 12.6%. Conclusion: the index of normalization of the segments of the Willis polygon and its variant forms contributed to bolder intervention planning in cerebrovascular disease treatment. Keywords: Circle of Willis, Cerebral arteries, MSCT.
摘要:对2019年1月至2019年12月在巴赫迈医院行脑动脉MSCT扫描的无脑血管畸形患者135例进行研究。结果:左、右A1段平均直径分别为2.28±0.47、2.19±0.53 mm;AcomA: 1.71±0.68 mm;左右M1段:2.82±0.46 mm和2.8±0.49 mm;左右PcomA分别为1.62±0.5 mm和1.67±0.48 mm;左、右P1段:2.22±0.49 mm、2.22±0.56 mm;左右P2节段:2.32±0.38 mm和2.35±0.36 mm;BA: 3.41±0.69 mm。两性脑动脉直径相似,威利斯环左右两侧无差异。Willis圈边缘直径从再生到发育不全不等,主要见于AcomA、PcomA、大脑前动脉A1段和大脑后动脉P1段。威利斯环的变形包括17种形式,其中4种是单纯的前部变形,4种是单纯的后部变形,9种是前后联合变形。AcomA和PcomA以发育不全或发育不全为主,分别为14.1%和12.6%。结论:Willis多边形节段的归一化指数及其变异形式有助于脑血管疾病治疗中更大胆的干预计划。关键词:威利斯圈,脑动脉,MSCT。
{"title":"The Features of the Circle of Willis on Multislice Computed Tomography in Humans Without Cerebral Vascular Malformations","authors":"Doan Van Ngoc, Tran Anh Tuan, Hoang Dinh Au","doi":"10.25073/2588-1132/vnumps.4351","DOIUrl":"https://doi.org/10.25073/2588-1132/vnumps.4351","url":null,"abstract":"Abstract: A study of 135 cases without cerebral vascular malformations who were scan MSCT of cerebral arteries at Bach Mai hospital during the period from January 2019 to December 2019. Result: mean diameter of cerebral artery segments: left and right A1 segments: 2.28 ± 0.47 and 2.19 ± 0.53 mm; AcomA: 1.71 ± 0.68 mm; left and right M1 segments: 2.82 ± 0.46 mm and 2.8 ± 0.49 mm; left and right PcomA: 1.62 ± 0.5 mm and 1.67 ± 0.48 mm; left and right P1 segments: 2.22 ± 0.49 mm and 2.22 ± 0.56 mm; left and right P2 segments: 2.32 ± 0.38 mm and 2.35 ± 0.36 mm; BA: 3.41 ± 0.69 mm. The diameters of the cerebral arteries were similar in both sexes, with no difference on the right and left sides of the ring of Willis. The diameter of the edges of the Willis circle varied from aplastic and hypoplastic, which was mainly seen in the AcomA, PcomA, the A1 segment of the anterior cerebral artery, and P1 of the posterior cerebral artery. The transformations of the Willis ring included 17 forms, of which four simple transformations of the anterior part, four simple transformations of the posterior part, and nine combined transformations between the anterior and posterior parts. Mainly found aplasia or hypoplasia of the AcomA 14.1% and the PcomA 12.6%. Conclusion: the index of normalization of the segments of the Willis polygon and its variant forms contributed to bolder intervention planning in cerebrovascular disease treatment. \u0000Keywords: Circle of Willis, Cerebral arteries, MSCT.","PeriodicalId":23520,"journal":{"name":"VNU Journal of Science: Medical and Pharmaceutical Sciences","volume":"15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86662025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Some Clinical and Subclinical Characteristics of Patients with Castration-resistant Prostate Cancer in Huu Nghi Hospital 胡义医院去势抵抗性前列腺癌患者的一些临床和亚临床特征
Pub Date : 2023-03-25 DOI: 10.25073/2588-1132/vnumps.4433
Abstract: This study aims to describe the clinical and subclinical characteristics of patients with castration-resistant prostate cancer (CRPC). The retrospective study was conducted on 46 patients with CRPC in Huu Nghi Hospital. The results indicated that the main clinical symptoms were bone pain (63.0%), hematuria (34.0%), and lower urinary tract symptoms (32.6%). The highest and lowest PSA concentrations were 611.3 ng/mL and 0.01 ng/mL, respectively. The most common sites of metastasis were bone (82.6%), lymph node (50.0%), and lung (19.6%). These patients were all at the late stage, so most of them had symptoms of metastasis and high PSA. Keywords: Prostate cancer, castration-resistant, clinical characteristics, subclinical characteristics.      
摘要:本研究旨在探讨去势抵抗性前列腺癌(CRPC)患者的临床和亚临床特征。本文对胡义医院46例CRPC患者进行回顾性研究。结果显示,主要临床症状为骨痛(63.0%)、血尿(34.0%)、下尿路症状(32.6%)。PSA浓度最高为611.3 ng/mL,最低为0.01 ng/mL。最常见的转移部位为骨(82.6%)、淋巴结(50.0%)和肺(19.6%)。这些患者均为晚期,多有转移和高PSA的症状。关键词:前列腺癌,去势抵抗,临床特征,亚临床特征。
{"title":"Some Clinical and Subclinical Characteristics of Patients with Castration-resistant Prostate Cancer in Huu Nghi Hospital","authors":"","doi":"10.25073/2588-1132/vnumps.4433","DOIUrl":"https://doi.org/10.25073/2588-1132/vnumps.4433","url":null,"abstract":"Abstract: This study aims to describe the clinical and subclinical characteristics of patients with castration-resistant prostate cancer (CRPC). The retrospective study was conducted on 46 patients with CRPC in Huu Nghi Hospital. The results indicated that the main clinical symptoms were bone pain (63.0%), hematuria (34.0%), and lower urinary tract symptoms (32.6%). The highest and lowest PSA concentrations were 611.3 ng/mL and 0.01 ng/mL, respectively. The most common sites of metastasis were bone (82.6%), lymph node (50.0%), and lung (19.6%). These patients were all at the late stage, so most of them had symptoms of metastasis and high PSA. \u0000Keywords: Prostate cancer, castration-resistant, clinical characteristics, subclinical characteristics. \u0000  \u0000  \u0000 ","PeriodicalId":23520,"journal":{"name":"VNU Journal of Science: Medical and Pharmaceutical Sciences","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87470184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of Drug Procurement Results in Vietnam from 2013 to 2020 2013 - 2020年越南药品采购结果分析
Pub Date : 2023-03-25 DOI: 10.25073/2588-1132/vnumps.4387
Nguyen Thi Hai Yen, Phung The Hiep, Nguyen Thi My Dung, Le Ngoc Danh, Thai Hue Ngan, Le Dang Tu Nguyen
Abstract: Drug procurement bidding has always been under the government’s particular concern to assure drug quality, stabilize drug costs, and enhance the use of domestic drugs. A retrospective study analyzes data from the drug procurement results in Vietnam from 2013 to 2020 based on the results reported to the Drug Administration of Vietnam. The rate of drugs selected through the bidding process in Hanoi and HCMC accounted for the highest proportion in the country with 17.5% and 14.3%, respectively. The number of selected drugs with domestic origins had seen a gradual increase over the years with 4545 drugs during 2020, which was 2.2 times higher than that of 2013 (2079 drugs). Generic drugs in group 3 with domestic origins comprised the highest proportion of both quantity and value compared to drugs in other groups. Antiparasitic drugs and anti-infectives had the highest value rates among pharmacological groups with over 20%. During the research period, the costs of selected drugs tended to witness a decreasing trend, accounting for 60% of drugs. Only 9% of the drugs had their values remain unchanged, and the other 31% saw an increase in these values. State bidding procurement policies are making positive effects in lowering drug costs and encouraging domestic drug use. However, the value rate of domestic drugs is still lower than that of imported ones. It is necessary for domestic pharmaceutical enterprises to invest in developing factories, actively find domestic ingredient sources, and focus on specific medications in great demand. Keywords: Drug bidding, drug price, generic bidding package, original brand name bidding package, period of 2013-2020, Vietnam.    
摘要:为保证药品质量,稳定药品成本,提高国内药品的利用率,药品采购招标一直受到政府的特别关注。一项回顾性研究分析了2013年至2020年越南药品采购结果的数据,该数据基于向越南药品管理局报告的结果。河内和胡志明市通过招标程序选择的药品比例在全国最高,分别为17.5%和14.3%。国产药品入选数量逐年增加,2020年达到4545种,是2013年(2079种)的2.2倍。第3组国产仿制药在数量和价值上均占其他组药品的最高比例。抗寄生虫药和抗感染药在药理学组中价值率最高,均超过20%。在研究期间,所选药物的成本呈下降趋势,占药物的60%。只有9%的药物的价值保持不变,其他31%的药物的价值增加了。国家招标采购政策在降低药品成本和鼓励国内用药方面发挥了积极作用。但是,国产药品的价值率仍然低于进口药品。国内制药企业有必要投资建厂,积极寻找国内原料来源,重点发展需求较大的特定药品。关键词:药品招标,药品价格,仿制药招标包装,原品牌招标包装,2013-2020年,越南
{"title":"Analysis of Drug Procurement Results in Vietnam from 2013 to 2020","authors":"Nguyen Thi Hai Yen, Phung The Hiep, Nguyen Thi My Dung, Le Ngoc Danh, Thai Hue Ngan, Le Dang Tu Nguyen","doi":"10.25073/2588-1132/vnumps.4387","DOIUrl":"https://doi.org/10.25073/2588-1132/vnumps.4387","url":null,"abstract":"Abstract: Drug procurement bidding has always been under the government’s particular concern to assure drug quality, stabilize drug costs, and enhance the use of domestic drugs. A retrospective study analyzes data from the drug procurement results in Vietnam from 2013 to 2020 based on the results reported to the Drug Administration of Vietnam. The rate of drugs selected through the bidding process in Hanoi and HCMC accounted for the highest proportion in the country with 17.5% and 14.3%, respectively. The number of selected drugs with domestic origins had seen a gradual increase over the years with 4545 drugs during 2020, which was 2.2 times higher than that of 2013 (2079 drugs). Generic drugs in group 3 with domestic origins comprised the highest proportion of both quantity and value compared to drugs in other groups. Antiparasitic drugs and anti-infectives had the highest value rates among pharmacological groups with over 20%. During the research period, the costs of selected drugs tended to witness a decreasing trend, accounting for 60% of drugs. Only 9% of the drugs had their values remain unchanged, and the other 31% saw an increase in these values. State bidding procurement policies are making positive effects in lowering drug costs and encouraging domestic drug use. However, the value rate of domestic drugs is still lower than that of imported ones. It is necessary for domestic pharmaceutical enterprises to invest in developing factories, actively find domestic ingredient sources, and focus on specific medications in great demand. \u0000Keywords: Drug bidding, drug price, generic bidding package, original brand name bidding package, period of 2013-2020, Vietnam. \u0000  \u0000 ","PeriodicalId":23520,"journal":{"name":"VNU Journal of Science: Medical and Pharmaceutical Sciences","volume":"65 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74102715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute and Repeated Dose 28-day Oral Toxicity Studies of Ich Tri Hadiphar Capsules Ich三Hadiphar胶囊急性和重复剂量28天口服毒性研究
Pub Date : 2023-03-25 DOI: 10.25073/2588-1132/vnumps.4405
Nguyen Thi Lien, Nguyen Thi Hang
Abstract:  Ich tri Hadiphar capsules used for dementia treatment were evaluated for acute and repeated dose toxicities in mice and rabbits, respectively. The acute toxicity results indicated that LD50 of Ich tri Hadiphar capsules in mice according to the method of Behrens is greater than 30 g/kg body weight. In the repeated dose toxicity study, rabbits were administrated Ich tri Hadiphar with doses of 186.5 and 560.0 mg/kg/day for 28 days (equivalent to the dose used on humans and the dose of 3 times more than one used on humans). Blood samples were taken on day 0, day 14, and day 28 of the experiment for hematological and biochemical analysis. Liver and kidney samples were taken on day 28 for histopathological determinations. The repeated dose toxicity results revealed that there were no significant differences in hematological and serum biochemical values between control and treatment animals. Furthermore, no histopathological changes in the liver and kidney of rabbits treated with Ich tri Hadiphar capsules were observed. Keywords: Acute toxicity, repeated dose toxicity, Ich tri Hadiphar.     
摘要:本研究分别在小鼠和家兔实验中评价了用于治疗痴呆的Ich tri Hadiphar胶囊的急性毒性和重复剂量毒性。急性毒性实验结果表明,按Behrens法给药的小鼠LD50大于30 g/kg体重。在重复给药毒性研究中,家兔以186.5和560.0 mg/kg/天的剂量连续28天(相当于人用剂量,是人用剂量的3倍以上)给予Ich trihadiphar。于实验第0天、第14天、第28天采血,进行血液学和生化分析。第28天取肝、肾标本进行组织病理学检查。重复剂量毒性试验结果显示,对照动物和处理动物的血液学和血清生化指标无显著差异。此外,Ich tri Hadiphar胶囊对家兔肝脏和肾脏未见组织病理学改变。关键词:急性毒性,重复剂量毒性,Ich tri Hadiphar。
{"title":"Acute and Repeated Dose 28-day Oral Toxicity Studies of Ich Tri Hadiphar Capsules","authors":"Nguyen Thi Lien, Nguyen Thi Hang","doi":"10.25073/2588-1132/vnumps.4405","DOIUrl":"https://doi.org/10.25073/2588-1132/vnumps.4405","url":null,"abstract":"Abstract:  Ich tri Hadiphar capsules used for dementia treatment were evaluated for acute and repeated dose toxicities in mice and rabbits, respectively. The acute toxicity results indicated that LD50 of Ich tri Hadiphar capsules in mice according to the method of Behrens is greater than 30 g/kg body weight. In the repeated dose toxicity study, rabbits were administrated Ich tri Hadiphar with doses of 186.5 and 560.0 mg/kg/day for 28 days (equivalent to the dose used on humans and the dose of 3 times more than one used on humans). Blood samples were taken on day 0, day 14, and day 28 of the experiment for hematological and biochemical analysis. Liver and kidney samples were taken on day 28 for histopathological determinations. The repeated dose toxicity results revealed that there were no significant differences in hematological and serum biochemical values between control and treatment animals. Furthermore, no histopathological changes in the liver and kidney of rabbits treated with Ich tri Hadiphar capsules were observed. \u0000Keywords: Acute toxicity, repeated dose toxicity, Ich tri Hadiphar.  \u0000 \u0000  \u0000 ","PeriodicalId":23520,"journal":{"name":"VNU Journal of Science: Medical and Pharmaceutical Sciences","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86508348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Semi-chronic Toxicity and Lipid-lowering Effect of Jasminum subtriplinerve Blume Oleaceae Extract 茉莉提取物半慢性毒性及降脂作用评价
Pub Date : 2023-03-25 DOI: 10.25073/2588-1132/vnumps.4409
Phan Hong Minh, Mai Phuong Thanh, Tran Thi Thu Trang, Ho My Dung
Abstract: Jasminum subtriplinerve Blume Oleaceae is a herbal medicine widely used for weight loss and milk gland stimulation. Extract product has been generally used but has not much scientific evidence about its safety and effects. This study aimed to evaluate the semi-chronic toxicity and lipid-lowering effects of Jasminum subtriplinerve Blume leaf extract. The study was performed on Wistar rats and Swiss mice. For semi-chronic toxicity, extracts at doses of 18 mg/kg/day and 54 mg/kg/day showed their safety after 90 days of continuous oral administration in Wistar rats. There was no effect on body weight, hematopoietic parameters, hepatocellular destruction, or liver and kidney function in experimental rats. For the lipid-lowering effect, the extracts at 36 mg/kg/day and 108 mg/kg/day showed a marked decrease in the blood lipid indexes (total cholesterol, triglycerides, non-HDL-C) after 7 days of dosing in Swiss mice on an endogenous dyslipidemic model induced by Poloxamer-407. Keywords: Jasminum subtriplinerve Blume Oleaceae, lipid-lowering, dyslipidemia, semi-chronic toxicity.  
摘要:茉莉科(Jasminum subtriplinerve Blume Oleaceae)是一种广泛用于减肥和刺激乳腺的草药。提取物产品已被广泛使用,但其安全性和效果并没有多少科学证据。本研究旨在评价茉莉叶提取物的半慢性毒性和降脂作用。这项研究是在Wistar大鼠和瑞士小鼠身上进行的。对于半慢性毒性,Wistar大鼠连续口服剂量为18 mg/kg/d和54 mg/kg/d的提取物在90天后显示出安全性。对实验大鼠的体重、造血参数、肝细胞破坏或肝肾功能没有影响。对于降脂作用,36 mg/kg/d和108 mg/kg/d的提取物在给药7天后,对瑞士小鼠内源性血脂异常模型的血脂指标(总胆固醇、甘油三酯、非hdl - c)明显降低。关键词:茉莉,降脂,血脂异常,半慢性毒性
{"title":"Assessment of Semi-chronic Toxicity and Lipid-lowering Effect of Jasminum subtriplinerve Blume Oleaceae Extract","authors":"Phan Hong Minh, Mai Phuong Thanh, Tran Thi Thu Trang, Ho My Dung","doi":"10.25073/2588-1132/vnumps.4409","DOIUrl":"https://doi.org/10.25073/2588-1132/vnumps.4409","url":null,"abstract":"Abstract: Jasminum subtriplinerve Blume Oleaceae is a herbal medicine widely used for weight loss and milk gland stimulation. Extract product has been generally used but has not much scientific evidence about its safety and effects. This study aimed to evaluate the semi-chronic toxicity and lipid-lowering effects of Jasminum subtriplinerve Blume leaf extract. The study was performed on Wistar rats and Swiss mice. For semi-chronic toxicity, extracts at doses of 18 mg/kg/day and 54 mg/kg/day showed their safety after 90 days of continuous oral administration in Wistar rats. There was no effect on body weight, hematopoietic parameters, hepatocellular destruction, or liver and kidney function in experimental rats. For the lipid-lowering effect, the extracts at 36 mg/kg/day and 108 mg/kg/day showed a marked decrease in the blood lipid indexes (total cholesterol, triglycerides, non-HDL-C) after 7 days of dosing in Swiss mice on an endogenous dyslipidemic model induced by Poloxamer-407. \u0000Keywords: Jasminum subtriplinerve Blume Oleaceae, lipid-lowering, dyslipidemia, semi-chronic toxicity. \u0000 ","PeriodicalId":23520,"journal":{"name":"VNU Journal of Science: Medical and Pharmaceutical Sciences","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87299672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potentialities of Antimicrobial Peptide Mastoparan C Isolated the European Hornet Vespa Crabro in Drug Discovery 欧洲大黄蜂抗菌肽Mastoparan C在药物开发中的潜力
Pub Date : 2023-03-25 DOI: 10.25073/2588-1132/vnumps.4489
Bui Thi Phuong Hai, Trinh Thi Kim Anh, Tran Thi Khanh Huyen, Luong Xuan Huy, Dang Thi Ngan, Bui Thi Thuong, N. Van Khanh, Nguyen Thi Thanh Hai, Nguyen Thi Thanh Binh
Abstract: Exploring the potential of natural bioactive peptides is becoming more and more important for new drug discovery. First isolated from the European wasp Vespa crabro, the antimicrobial peptide Mastoparan C was found in higher content than many other molecules in the Mastoparan family. In addition to the mast cell degranulation that is similar to some components in insect venom, this compound possesses remarkable biological activities such as broad-spectrum antibacterial and antifungal, inhibiting the proliferation of many human cancer cell lines. However, unfortunately, Mastoparan C has the notable side effect of causing mammalian hemolysis. By investigating its structure-activity relationships, this review pointed out some suggestions to overcome the disadvantages of this potential peptide and thereby support further in-depth study in the drug discovery field. Keywords: Mastoparan C, antimicrobial peptide, biological activity, structure-activity relationships.
摘要:探索天然生物活性肽的潜力对新药开发越来越重要。抗菌肽Mastoparan C首次从欧洲黄蜂(Vespa crabro)中分离出来,其含量高于Mastoparan家族的许多其他分子。该化合物除具有类似于昆虫毒液中某些成分的肥大细胞脱颗粒作用外,还具有广谱抗菌、抗真菌等显著的生物活性,可抑制多种人类癌细胞系的增殖。然而,不幸的是,Mastoparan C具有引起哺乳动物溶血的显著副作用。本文通过对其构效关系的研究,提出了一些建议,以克服该潜在肽的不足,从而为药物发现领域的进一步深入研究提供支持。关键词:Mastoparan C,抗菌肽,生物活性,构效关系
{"title":"Potentialities of Antimicrobial Peptide Mastoparan C Isolated the European Hornet Vespa Crabro in Drug Discovery","authors":"Bui Thi Phuong Hai, Trinh Thi Kim Anh, Tran Thi Khanh Huyen, Luong Xuan Huy, Dang Thi Ngan, Bui Thi Thuong, N. Van Khanh, Nguyen Thi Thanh Hai, Nguyen Thi Thanh Binh","doi":"10.25073/2588-1132/vnumps.4489","DOIUrl":"https://doi.org/10.25073/2588-1132/vnumps.4489","url":null,"abstract":"Abstract: Exploring the potential of natural bioactive peptides is becoming more and more important for new drug discovery. First isolated from the European wasp Vespa crabro, the antimicrobial peptide Mastoparan C was found in higher content than many other molecules in the Mastoparan family. In addition to the mast cell degranulation that is similar to some components in insect venom, this compound possesses remarkable biological activities such as broad-spectrum antibacterial and antifungal, inhibiting the proliferation of many human cancer cell lines. However, unfortunately, Mastoparan C has the notable side effect of causing mammalian hemolysis. By investigating its structure-activity relationships, this review pointed out some suggestions to overcome the disadvantages of this potential peptide and thereby support further in-depth study in the drug discovery field. \u0000Keywords: Mastoparan C, antimicrobial peptide, biological activity, structure-activity relationships.","PeriodicalId":23520,"journal":{"name":"VNU Journal of Science: Medical and Pharmaceutical Sciences","volume":"12 9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77896791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research on the Preparation of Self-nano-emulsifying Drug Delivery System Containing Gynostemma pentaphyllum Dry Extract for Application in Skin Care Cosmetics 含绞绞线干提取物的自纳米乳化给药体系的制备及其在护肤品中的应用研究
Pub Date : 2023-03-25 DOI: 10.25073/2588-1132/vnumps.4488
Vu Thi Thu Giang, Pham Thuy Hanh, Nguyen Van Lam
Abstract: Gynostemma pentaphyllum (Thunb.) Makino is a rich source of the herb in Vietnam. The gypenosides in this herb are triterpenoid saponins that have been shown to have moisturizing, antioxidant, and anti-aging effects on the skin. However, gypenosides are hydrophilic and have a large molecular weight with a bulk molecular structure which prevents them from penetrating and absorbing into the skin. To apply the natural active ingredients from herbs into skin care cosmetics, this research developed self-nano-emulsifying drug delivery systems (SNEDDS) containing Gynostemma pentaphyllum dry extract and applied them to emulgel skin care cosmetics. Prepared SNEDDS could self-emulsify in the water to form nanoemulsions with dispersed droplet sizes less than 20 nm with PDI < 0.3. The proportion of saponin entrapped in the oil droplets of nano emulsification was more than 90%. When combined with emulgel excipients, the obtained cosmetic products had nano-sized dispersed droplets less than 200 nm with uniform droplet size distribution, which are promising for application when further research is carried out. Keywords: Self-nano-emulsifying Drug Delivery System (SNEDDS), Gymnostemma pentaphyllum dry extract, cosmetic, emulgel, nano-emulsion.    
摘要:绞股蓝(Gynostemma pentaphyllum)牧野是越南丰富的香草产地。这种草药中的绞股蓝苷是三萜皂苷,已被证明对皮肤有保湿、抗氧化和抗衰老的作用。然而,绞股蓝皂苷是亲水的,具有较大的分子量,具有较大的分子结构,这阻止了它们渗透和吸收到皮肤中。为了将天然有效成分应用于护肤化妆品中,本研究开发了含有绞绞线干提取物的自纳米乳化给药系统(SNEDDS),并将其应用于乳状护肤化妆品中。制备的SNEDDS可在水中自乳化形成纳米乳液,分散液滴粒径小于20 nm, PDI < 0.3。纳米乳化油滴中皂苷的包被率达90%以上。当与乳状辅料联合使用时,得到的化妆品具有小于200 nm的纳米级分散液滴,且液滴尺寸分布均匀,在进一步的研究中具有良好的应用前景。关键词:自纳米乳化给药系统(SNEDDS),裸子籽干提取物,化妆品,凝胶,纳米乳液
{"title":"Research on the Preparation of Self-nano-emulsifying Drug Delivery System Containing Gynostemma pentaphyllum Dry Extract for Application in Skin Care Cosmetics","authors":"Vu Thi Thu Giang, Pham Thuy Hanh, Nguyen Van Lam","doi":"10.25073/2588-1132/vnumps.4488","DOIUrl":"https://doi.org/10.25073/2588-1132/vnumps.4488","url":null,"abstract":"Abstract: Gynostemma pentaphyllum (Thunb.) Makino is a rich source of the herb in Vietnam. The gypenosides in this herb are triterpenoid saponins that have been shown to have moisturizing, antioxidant, and anti-aging effects on the skin. However, gypenosides are hydrophilic and have a large molecular weight with a bulk molecular structure which prevents them from penetrating and absorbing into the skin. To apply the natural active ingredients from herbs into skin care cosmetics, this research developed self-nano-emulsifying drug delivery systems (SNEDDS) containing Gynostemma pentaphyllum dry extract and applied them to emulgel skin care cosmetics. Prepared SNEDDS could self-emulsify in the water to form nanoemulsions with dispersed droplet sizes less than 20 nm with PDI < 0.3. The proportion of saponin entrapped in the oil droplets of nano emulsification was more than 90%. When combined with emulgel excipients, the obtained cosmetic products had nano-sized dispersed droplets less than 200 nm with uniform droplet size distribution, which are promising for application when further research is carried out. \u0000Keywords: Self-nano-emulsifying Drug Delivery System (SNEDDS), Gymnostemma pentaphyllum dry extract, cosmetic, emulgel, nano-emulsion. \u0000 \u0000  \u0000 ","PeriodicalId":23520,"journal":{"name":"VNU Journal of Science: Medical and Pharmaceutical Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88642875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Towards Developing Quantitative Structure-activity Relationship Models for the Design of Novel Influenza A Inhibitors Targeting Neuraminidase 为设计新型靶向神经氨酸酶的甲型流感抑制剂建立定量构效关系模型
Pub Date : 2023-03-25 DOI: 10.25073/2588-1132/vnumps.4412
Ly Cong Thanh
Abstract: Anti-influenza-A drugs targeting viral neuraminidase have been in use for two decades. In this study, the quantitative structure-activity relationships (QSAR) of oseltamivir derivatives as influenza neuraminidase (IN) inhibitors have been explored using the Monte Carlo method based on the target function involving the index of the ideality of correlation. Three best-obtained models showed appropriate performance with R2 values of training and test sets ranging from 0.71 to 0.86, respectively. Based on the structural information extracted from the models, new inhibitors were designed and predicted for IN activities. Finally, protein docking was applied to confirm their target binding ability. Keyword: Anti-influenza A; neuramidase inhibitor; drug design; QSAR; docking.    
摘要:针对病毒神经氨酸酶的抗流感药物已经使用了20年。本研究采用蒙特卡罗方法,基于相关理想性指标的目标函数,探讨了奥司他韦衍生物作为流感神经氨酸酶抑制剂的定量构效关系(QSAR)。3个最佳模型的训练集和测试集的R2值分别在0.71 ~ 0.86之间,表现出较好的性能。基于从模型中提取的结构信息,设计并预测了新的抑制剂的IN活性。最后,通过蛋白对接来确认它们的靶标结合能力。关键词:抗甲型流感;neuramidase抑制剂;药物设计;构象;对接。
{"title":"Towards Developing Quantitative Structure-activity Relationship Models for the Design of Novel Influenza A Inhibitors Targeting Neuraminidase","authors":"Ly Cong Thanh","doi":"10.25073/2588-1132/vnumps.4412","DOIUrl":"https://doi.org/10.25073/2588-1132/vnumps.4412","url":null,"abstract":"Abstract: Anti-influenza-A drugs targeting viral neuraminidase have been in use for two decades. In this study, the quantitative structure-activity relationships (QSAR) of oseltamivir derivatives as influenza neuraminidase (IN) inhibitors have been explored using the Monte Carlo method based on the target function involving the index of the ideality of correlation. Three best-obtained models showed appropriate performance with R2 values of training and test sets ranging from 0.71 to 0.86, respectively. Based on the structural information extracted from the models, new inhibitors were designed and predicted for IN activities. Finally, protein docking was applied to confirm their target binding ability. \u0000Keyword: Anti-influenza A; neuramidase inhibitor; drug design; QSAR; docking. \u0000  \u0000 ","PeriodicalId":23520,"journal":{"name":"VNU Journal of Science: Medical and Pharmaceutical Sciences","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81853356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
VNU Journal of Science: Medical and Pharmaceutical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1